[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100191056":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":35,"responsibleParty":55,"collaborators":10,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Helse Stavanger HF","OTHER_GOV",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"open and laparoscopic surgery",null,"Patients with primary and or metastatic colorectal cancer (CRC) eligible for curative surgery will be included. Subcohorts may be based on either colon cancer, rectal cancer, metastatic cancer, surgery (laparoscopy or open), node negative and node positive disease, and molecular profiling.",[13],"Procedure: open and laparoscopic surgery",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"PROCEDURE","Curative surgery for either primary (colorectal cancer, crc) or metastatic CRC (liver surgery)",[9],[20],"Liver surgery",[22],{"name":23,"affiliation":5,"role":24},"Kjetil Søreide, MD, PhD, FRCS, FACS","PRINCIPAL_INVESTIGATOR",[26,32],{"name":27,"role":28,"phone":29,"phoneExt":30,"email":31},"Ramesh L. Kajavi, RN","CONTACT","92297672","47","acro.gitan@gmail.com",{"name":33,"role":28,"phone":10,"phoneExt":10,"email":34},"Marina Alexeeva, PhD","marina.alexeeva@sus.no",[36],{"facility":37,"status":38,"city":39,"state":10,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Stavanger University Hospital","RECRUITING","Stavanger","4068","Norway","NO",{"type":44,"coordinates":45},"Point",[46,47],5.73332,58.97005,{"lat":47,"lon":46},[50,54],{"name":51,"role":28,"phone":52,"phoneExt":30,"email":53},"Kjetil Søreide, MD, PhD","92281557","ksoreide@mac.com",{"name":51,"role":24,"phone":10,"phoneExt":10,"email":10},{"type":56,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100191056","assessment-of-clinically-related-outcomes-and-biomarker-analysis-for-translational-integration-in-colorectal-cancer-100191056",false,"NCT01762813","Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer","Prospective, Population-based Cohort Collection of Blood Samples and Tumor Tissue From Patients Operated on for Primary or Metastatic Colorectal Cancer","ACROBATICC","Inclusion Criteria:\n\n* Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery\n* Informed consent to participate\n* Age ≥18\n\nExclusion Criteria:\n\n* failure to provide written informed consent","ALL","18 Years",{"count":68,"type":69},1200,"ESTIMATED","OBSERVATIONAL","* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer\n* Prospective collection of tissues to explore potential biomarkers in blood and\u002For primary or secondary cancers and\u002For normal colon",[73],"Colorectal Cancer",[75,76,77,78,79,80],"Colon cancer","rectal cancer","liver metastasis","survival","biomarker","molecular profile","2026-04-25",{"date":83,"type":84},"2026-04-30","ACTUAL",{"date":86,"type":84},"2013-01-01",{"date":88,"type":69},"2036-12-31",{"name":5,"class":6},1]